Skip to main content
Mega Genomics Limited logo

Mega Genomics Limited — Investor Relations & Filings

Ticker · 6667 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 317 across all filing types
Latest filing 2025-01-28 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 6667

About Mega Genomics Limited

https://www.megagenomics.cn

Mega Genomics Limited operates as a genetic testing platform company focused on providing consumer genetic testing and cancer screening services. The core business involves delivering comprehensive genetic analysis solutions to the consumer market. Key product offerings include advanced sequencing packages such as Personal Whole Genome Sequencing, which analyzes over 700,000 genetic loci to assess disease risk and provide pharmacogenomic recommendations. Additionally, the company offers Adult and Children's Whole Exome Sequencing packages, which analyze over 180,000 key exome regions to evaluate risks for high-risk diseases, hereditary cancers, and complex genetic disorders, alongside personalized guidance on drug efficacy, nutrition, and fitness.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) covering changes in issued shares and treasury shares, specifically detailing multiple share repurchases, confirmations under Main Board/GEM rules, and the repurchase report (Section II). This is clearly a report of the company buying back its own shares. Therefore, it falls under Transaction in Own Shares (share repurchase/issuance).
2025-01-28 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a formal "Next Day Disclosure Return" (Form FF305) under Hong Kong Stock Exchange rules, detailing changes in issued shares and treasury shares, including a section on repurchased shares (on-market share buybacks) and confirmations. It is not an earnings release, annual report, AGM material, or proxy statement; rather it is a mandated disclosure of the company’s transactions in its own shares (buybacks). Therefore it fits the "Transaction in Own Shares" category (POS).
2025-01-28 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) filed under Hong Kong Listing Rules, detailing changes in issued shares and treasury shares, specifically share repurchases and cancellations. This is a company-initiated buyback transaction disclosure. It is not an earnings release, annual report, or management change notice, but a report of transactions in the issuer’s own shares. Therefore it falls under Transaction in Own Shares (POS).
2025-01-21 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a ‘Next Day Disclosure Return’ (Form FF305) filed under Hong Kong listing rules, detailing changes in issued shares and extensive on-market share repurchases (Sections I–II cover share redemption/repurchase events and a repurchase report). This is not an earnings release, AGM material, or annual/quarterly report, but a regulatory disclosure of share buybacks. It matches our definition for “Transaction in Own Shares” (POS).
2025-01-17 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is titled “Next Day Disclosure Return” (Form FF305) under Hong Kong Listing Rules, detailing changes in issued shares and extensive records of on‐market repurchases (share buybacks) by Mega Genomics Limited, including dates, volumes, and prices. This is a direct disclosure of the company’s own share transactions (repurchase) rather than a broader financial report, dividend notice, or regulatory announcement with other purposes. Therefore it matches the “Transaction in Own Shares” category (POS).
2025-01-16 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return under the HKEX listing rules (FF305) detailing changes in issued shares and extensive tables of shares repurchased (dates, quantities, prices), plus a separate repurchase report in Section II. It clearly reports transactions in the company’s own shares. Therefore, it matches the “Transaction in Own Shares” category (POS).
2025-01-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.